Di Nuzzo Private Wealth, Inc. Agios Pharmaceuticals, Inc. Transaction History
Di Nuzzo Private Wealth, Inc.
- $618 Million
- Q4 2024
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 6 shares of AGIO stock, worth $185. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6
Previous 2
200.0%
Holding current value
$185
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AGIO
# of Institutions
243Shares Held
59.9MCall Options Held
270KPut Options Held
332K-
Farallon Capital Management LLC San Francisco, CA5.67MShares$175 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$174 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$150 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$108 Million2.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.42MShares$74.7 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.69B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...